Sweden· SE-19910322000023
Livostin 0,5 mg/ml Ögondroppar, suspension
A medicinal product containing levocabastine, registered in Sweden by McNeil Sweden AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Levocabastine
- Manufacturer
- McNeil Sweden AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19910322000023
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levocabastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLivostin 0.5 mg/mlPI Pharma
- FinlandLivostinParanova Oy
- CzechiaLIVOSTINMcNeil Healthcare (Ireland) Limited, Dublin
- IcelandLivostinMcNeil Sweden AB
- NetherlandsLivocab 0,5 mg/ml oogdruppels, suspensieKenvue Netherlands B.V.
- NorwayLivostinMcNeil Sweden AB
- GermanyLevocabastinDermapharm Ag
- United KingdomLivostin 0.05% nasal sprayNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Levocamed, Livostin
- Belgium · Livostin, Nasasinuspray Anti-Allergie
- Czechia · Livostin
- Germany · Levocabastin, Levocamed
- Denmark · Benaliv
- Spain · Bilina, Reactine
- Finland · Livostin
- France · Allergiflash, Levofree
- Greece · Livostin
- Iceland · Livostin
- Italy · Levoreact, Levoreact Oftalmico
- Luxembourg · Livostin, Nasasinuspray Anti-Allergie
- Netherlands · Livocab
- Norway · Livostin
- Slovakia · Livostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6cab90dc-b7cb-4d2a-91ac-0e371a9ec104 GET /v1/drugs/6cab90dc-b7cb-4d2a-91ac-0e371a9ec104?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19910322000023",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19910322000023",
"product_doc_link": "https://docetp.mpa.se/LMF/Livostin%20eye%20drops%2C%20suspension%20SmPC_09001bee807a5c91.pdf"
}See everything about levocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.